GSK Acquires Rapt Therapeutics in $2.2 Billion Deal for Food Allergy Drug
GSK has agreed to acquire Rapt Therapeutics in a transaction valued at approximately USD 2.2 billion, securing rights to the […]
2-2-BILLION-DEAL
GSK has agreed to acquire Rapt Therapeutics in a transaction valued at approximately USD 2.2 billion, securing rights to the […]
